Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
14C-UCB0942 mass balance and pharmacokinetics study in healthy men
NL-OMON35304Active, not recruiting
- Sponsor
- UCB
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of padsevonil in epilepsy, sponsored by UCB. Primary endpoints: Excretion balance of total radioactivity, Pharmacokinetics of total radioactivity and 3 more. Started Dec 2011; status: active, not recruiting.
02
Drugs
padsevonil
03
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON35304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35304.